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same for series with similar rates of critical ischaemia. 
Is this necessarily the case? Let us study the few 
surveillance series which quote amputation rates. In 
the publication of Sayer et al.9 in which all patients 
are stated to have critical ischaemia, 25 of the 33 (75%) 
occluded grafts resulted in amputations. Whereas in 
the article of Berkowitz and Greenstein, 4 in which all 
patients are stated to have severely ischaemic legs, 
only 11 of the 25 (44%) occluded grafts resulted in 
amputation. Clearly there appears to be variation in 
the outcome of graft occlusion in the presence of 
critical ischaemia. Thus any analysis based on the 
hypothesis that the ratio of occlusion to amputation 
is equal must be invalid. 
As stated in the discussion of our publication, we 
accept hat the summation analysis has a number of 
difficulties. The results do not demonstrate hat duplex 
surveillance has no role following infrainguinal by- 
pass, but they do indicate that a large randomised trial 
is warranted to establish that the considerable cost 
and workload required for surveillance isworthwhile. 
Surely this is the only scientific way of establishing 
the role of duplex surveillance rather than any hypo- 
thesis that the ratio of amputation to occlusion should 
be equal for disparate groups or the demonstration 
that secondary patency is significantly better than 
primary patency3 
J. Golledge and A.H. Davies 
Charing Cross Hospital, London, U.K. 
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Iloprost 
Sir, 
Having been involved with the early trials of iloprost as 
an adjunct o distal bypass urgery, we were naturally 
disappointed that the multi-centre trial reported in 
this journal failed to show any benefit of the agent in 
this role. 1 We believe, however, that the results of the 
study should be interpreted with great caution for a 
number of reasons. 
Initial experience with iloprost was carried out using 
a single bolus dose of the agent via a vein graft to a single 
calf vessel on completion of the procedure. Addition of 
intravenous iloprost before and after surgery is without 
proven benefit and may, as the authors discuss, even 
be disadvantageous. It is further disappointing that 45 
patients failed to receive iloprost as planned. 
Our major concern relates to the study design. The 
initial power calculations for the study were based on 
the results of patients undergoing arterial bypass to a 
single calf vessel using long saphenous vein. In the re- 
ported study only 73.9% of patients received such a 
procedure, and the inclusion of patients with composite 
and prosthetic grafts invalidates the initial calculations. 
Subsequent subgroup analysis of the different grafts is 
not valid due to the small numbers and is possibly one of 
the factors contributing to the surprising lack of benefit 
found for vein compared to prosthetic grafts. 
Patient selection and surgical technique are of fun- 
damental importance in distal bypass urgery, and the 
variation in number of procedures performed by each 
centre (one unit contributing only one) suggests con- 
siderable differences existed. This point is reinforced by 
the variable use of dextran, antiplatelet agents, heparin 
and anaesthetic technique. All of these factors introduce 
further variables which reduce the power of the study. 
It is likely that publication of this study will kill 
further interest in the role of iloprost as an adjunct o 
distal bypass surgery. We think that this may be a 
pity and suggest hat what the study most strongly 
illustrates is the need for robust study design before 
interpreting the results from multi-centre trials. 
C.P. Shearman 
Southampton, U.K. 
EC.T. Smith 
Bristol, U.K. 
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Transcranial Doppler 
Sir, 
We read with interest he article of Giannoni et al. 1 
regarding the changes seen on transcranial doppler 
compared with clinical condition when performing a
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